Fulvestrant Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
GTHX | A | G1 Therapeutics, Inc. | 0.00 | |
OLMA | F | Olema Pharmaceuticals, Inc. | -1.81 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
ARB | B | AltShares Merger Arbitrage ETF | 1.72 | |
EVNT | B | AltShares Event-Driven ETF | 0.77 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.64 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.37 | |
XBI | D | SPDR S&P Biotech ETF | 0.13 |
Compare ETFs
- Fulvestrant
Fulvestrant, sold under the brand name Faslodex among others, is a medication used to treat hormone receptor (HR)-positive metastatic breast cancer in postmenopausal women with disease progression as well as HR-positive, HER2-negative advanced breast cancer in combination with palbociclib in women with disease progression after endocrine therapy. It is given by injection into a muscle.Fulvestrant is a selective estrogen receptor degrader (SERD) and was first-in-class to be approved. It works by binding to the estrogen receptor and destabilizing it, causing the cell's normal protein degradation processes to destroy it.Fulvestrant was approved for medical use in the United States in 2002.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles